Displaying 1 - 12 items out of 21 results
Press release
… 2021, 9 a.m. GMT/10 a.m. CDT/11 a.m. EDT) --Pre-treatment circulating tumor (ct)DNA levels more accurately predicted long-term survival than …
Press release
… PD-L1 inhibition overcomes T-cell suppression at the tumor; and chemotherapy causes tumor cell death and antigen … molecularly characterized via sequencing of tumor tissue DNA and/or circulating tumor DNA samples. Progression free survival and …
Press release
… complex malignancy. Liquid biopsy, and especially plasma ctDNA, can be used in many clinical settings where tissue is … that IASLC is in the forefront in this arena.” Although tumor tissue is historically the gold standard biospecimen … biopsy approach includes a variety of methodologies for circulating analytes. From a clinical point of view, plasma …
ILCN article
The Promise of Artificial Intelligence-Aided Pathology in Thoracic Oncology
… Assessment of tumor material by the pathology laboratory has become a … who must maintain in-depth knowledge of rapidly changing tumor classification and staging systems as well as of … The detection of targetable genomic alterations by DNA and RNA sequencing has become a mainstay for prediction …
Press release
… a powerful tool that can determine the patient’s molecular tumor profile in order to determine the best therapeutic … applied as an alternative to tissue testing in cases where tumor testing is not possible or tissue is not adequate,” … rebiopsies. In this context, the isolation of tumor-derived DNA, RNA and cells from the peripheral circulation (a …
Webinar
… molecular candidates, such as autoantibodies, microRNAs, circulating tumor DNA, blood protein profiling, etc. Other emerging …
Spotlight
… of lung cancers harboring mutations in genes involved in DNA damage repair (DDR) derive improved clinical outcomes … of lung cancers harboring mutations in genes involved in DNA damage repair (DDR) derive improved clinical outcomes … in DDR genes are increasingly being identified in other tumor types, our findings could extend to other cancers in …
Press release
… Barcelona— Tumor mutational burden was not significantly associated … Garassino from theFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Dr. Garassino presented this new data … by whole-exome sequencing of tumor and matched normal DNA. The clinical utility of TMB on outcomes was assessed …
Press release
… specific cancer’s growth and progression. Patients whose tumors harbor certain, specific molecular alterations may be … EGFR T790M in relapse may be done by biopsy or cell-free circulating DNA. However cell-free DNA is not appropriate for initial …
Landing page
… many major categories of lung cancer research, from tumor staging to tobacco control and smoking cessation. 2023 … achievements that provides clinical evidence for the use of circulating tumor DNA(ctDNA)-based biomarker. This work broke the bottlenecks …
Press release
… predictive biomarkers, which may enable better targeting of tumor characteristics. Its aims to accelerate development of … and novel diagnostic approaches – like the detection of circulating tumor DNA in blood samples – to identify patients with a poor …